326 related articles for article (PubMed ID: 28721448)
1. [PI-RADS 2.0 for Prostate MRI].
Franiel T; Röthke M
Radiologe; 2017 Aug; 57(8):665-678. PubMed ID: 28721448
[TBL] [Abstract][Full Text] [Related]
2. Prostate MRI based on PI-RADS version 2: how we review and report.
Steiger P; Thoeny HC
Cancer Imaging; 2016 Apr; 16():9. PubMed ID: 27067275
[TBL] [Abstract][Full Text] [Related]
3. Review of Prostate Imaging Reporting and Data System version 2.
Wahab SA; Verma S
Future Oncol; 2016 Nov; 12(21):2479-2494. PubMed ID: 27646879
[TBL] [Abstract][Full Text] [Related]
4. Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)-do we still need contrast media?
Huebner NA; Korn S; Resch I; Grubmüller B; Gross T; Gale R; Kramer G; Poetsch N; Clauser P; Haitel A; Fajkovic H; Shariat SF; Baltzer PA
Eur Radiol; 2021 Jun; 31(6):3754-3764. PubMed ID: 33263793
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
6. Dynamic Contrast Enhanced Magnetic Resonance Imaging Improves Classification of Prostate Lesions: A Study of Pathological Outcomes on Targeted Prostate Biopsy.
Druskin SC; Ward R; Purysko AS; Young A; Tosoian JJ; Ghabili K; Andreas D; Klein E; Ross AE; Macura KJ
J Urol; 2017 Dec; 198(6):1301-1308. PubMed ID: 28709889
[TBL] [Abstract][Full Text] [Related]
7. Prostate imaging reporting and data system version 2 (PI-RADS v2): a pictorial review.
Hassanzadeh E; Glazer DI; Dunne RM; Fennessy FM; Harisinghani MG; Tempany CM
Abdom Radiol (NY); 2017 Jan; 42(1):278-289. PubMed ID: 27522352
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance and reproducibility of T2w based and diffusion weighted imaging (DWI) based PI-RADSv2 lexicon descriptors for prostate MRI.
Benndorf M; Hahn F; Krönig M; Jilg CA; Krauss T; Langer M; Dovi-Akué P
Eur J Radiol; 2017 Aug; 93():9-15. PubMed ID: 28668436
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric MRI for Suspected Recurrent Prostate Cancer after HIFU:Is DCE still needed?
Lotte R; Lafourcade A; Mozer P; Conort P; Barret E; Comperat E; Ezziane M; de Guibert PJ; Tavolaro S; Belin L; Boudghene F; Lucidarme O; Renard-Penna R
Eur Radiol; 2018 Sep; 28(9):3760-3769. PubMed ID: 29633004
[TBL] [Abstract][Full Text] [Related]
10. Prostate Cancer: The European Society of Urogenital Radiology Prostate Imaging Reporting and Data System Criteria for Predicting Extraprostatic Extension by Using 3-T Multiparametric MR Imaging.
Kayat Bittencourt L; Litjens G; Hulsbergen-van de Kaa CA; Turkbey B; Gasparetto EL; Barentsz JO
Radiology; 2015 Aug; 276(2):479-89. PubMed ID: 25848900
[TBL] [Abstract][Full Text] [Related]
11. Central zone lesions on magnetic resonance imaging: Should we be concerned?
Tan WP; Mazzone A; Shors S; Antoine N; Ekbal S; Khare N; McKiel C; Pessis D; Deane L
Urol Oncol; 2017 Jan; 35(1):31.e7-31.e12. PubMed ID: 27692837
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of prostatitis and prostate cancer using the Prostate Imaging-Reporting and Data System (PI-RADS).
Meier-Schroers M; Kukuk G; Wolter K; Decker G; Fischer S; Marx C; Traeber F; Sprinkart AM; Block W; Schild HH; Willinek W
Eur J Radiol; 2016 Jul; 85(7):1304-11. PubMed ID: 27235878
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric MRI of the prostate: diagnostic performance and interreader agreement of two scoring systems.
Lin WC; Muglia VF; Silva GE; Chodraui Filho S; Reis RB; Westphalen AC
Br J Radiol; 2016 Jun; 89(1062):20151056. PubMed ID: 27007818
[TBL] [Abstract][Full Text] [Related]
14. Population net benefit of prostate MRI with high spatiotemporal resolution contrast-enhanced imaging: A decision curve analysis.
Prabhu V; Rosenkrantz AB; Otazo R; Sodickson DK; Kang SK
J Magn Reson Imaging; 2019 May; 49(5):1400-1408. PubMed ID: 30629317
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the compliance with minimum acceptable technical parameters proposed by PI-RADS v2 guidelines in multiparametric prostate MRI acquisition in tertiary referral hospitals in the Republic of Turkey.
Coşkun M; Sarp AF; Karasu Ş; Gelal MF; Türkbey B
Diagn Interv Radiol; 2019 Nov; 25(6):421-427. PubMed ID: 31650967
[TBL] [Abstract][Full Text] [Related]
16. PI-RADS Version 2: A Pictorial Update.
Purysko AS; Rosenkrantz AB; Barentsz JO; Weinreb JC; Macura KJ
Radiographics; 2016; 36(5):1354-72. PubMed ID: 27471952
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate.
Baur AD; Maxeiner A; Franiel T; Kilic E; Huppertz A; Schwenke C; Hamm B; Durmus T
Invest Radiol; 2014 Jun; 49(6):411-20. PubMed ID: 24598440
[TBL] [Abstract][Full Text] [Related]
18. A self-tuned graph-based framework for localization and grading prostate cancer lesions: An initial evaluation based on multiparametric magnetic resonance imaging.
Chen W; Lin M; Gibson E; Bastian-Jordan M; Cool DW; Kassam Z; Liang H; Feng G; Ward AD; Chiu B
Comput Biol Med; 2018 May; 96():252-265. PubMed ID: 29653354
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric Magnetic Resonance Imaging of the Prostate for Tumour Detection and Local Staging: Imaging in 1.5T and Histopathologic Correlation.
Loggitsi D; Gyftopoulos A; Economopoulos N; Apostolaki A; Kalogeropoulos T; Thanos A; Alexopoulou E; Kelekis NL
Can Assoc Radiol J; 2017 Nov; 68(4):379-386. PubMed ID: 28720413
[TBL] [Abstract][Full Text] [Related]
20. Utility of Quantitative T2-Mapping Compared to Conventional and Advanced Diffusion Weighted Imaging Techniques for Multiparametric Prostate MRI in Men with Hip Prosthesis.
Sathiadoss P; Schieda N; Haroon M; Osman H; Alrasheed S; Flood TA; Melkus G
J Magn Reson Imaging; 2022 Jan; 55(1):265-274. PubMed ID: 34223675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]